Evaluating Tools to Communicate Scleroderma Research Results to Patients - Trial #1

Sharing research results with patients is required by ethical regulations. Yet, most researchers do not share results from their studies with patients. The investigators plan to conduct a series of randomized controlled trials among people with scleroderma, a rare autoimmune disease, in a large international cohort, to identify the most effective methods for communicating study results with patients. The first trial in the series will compare a research dissemination tool (infographic) against a plain-language summary comparator. Participants will be randomly assigned to receive the dissemination tool or comparator. Study participants will rate communication tools for (1) information completeness; (2) understandability; and (3) ease of use of format. Our results can be used by researchers and patient organizations who disseminate research results so that they can tailor the way they disseminate results to patient needs.

NCT Number	NCT06373263
Lead Sponsor	Lady Davis Institute
Conditions	Scleroderma, Systemic Sclerosis
Enrollment	128 participants
Start Date	2025-12-05
Primary Completion	2025-12-19 (estimated)
Study Completion	2026-01-02 (estimated)
Updated on ClinicalTrials.gov	2025-12-08